chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I tested positive for COVID-19; no treatment was given. I had a runny nose, sore throat, shortness of breath, and a persistent dry cough. I had no fever and it lasted for five days.
Shingles; Rash; Cracking skin; Dry Skin; This case was reported by a physician via call center representative and described the occurrence of shingles in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd May 2019, the patient received the 1st dose of Shingrix (intramuscular) 50 ug. In May 2019, less than a month after receiving Shingrix, the patient experienced chapped skin and dry skin. On 21st May 2019, the patient experienced shingles and rash. On an unknown date, the outcome of the shingles, rash, chapped skin and dry skin were unknown.   It was unknown if the reporter considered the shingles, rash, chapped skin and dry skin to be related to Shingrix.  Additional details were provided as follows: The patient developed a rash and was diagnosed with Shingles on 23rd May 2019 by one of the other physician in the office.  The physician reported that the patient called on 30th May 2019 and stated she was still having cracking and drying of the skin.  The patient was going to see physician on the day of reporting. No further details were provided.
I went to work the day after shot #2. I began feeling very achy  in the afternoon.  I also had chills and a slight headache. The aches grew worse into the evening.  I took tylenol and went to sleep.  I woke up with a huge headache and stayed home. Slept till 11am. Woke up feeling fine.
Started have headaches and feeling dizzy. On Sunday 04/18/2021 systoms became reaaly pronounced. Even felt as if my breading was erratic.
This is from the Moderna booster shot:   Fever, severe headache, bump/swelling/redness at injection site, severe fatigue, weakness, facial numbness, confusion, heart racing, lower oxygen, dizziness, eye pain, shortness of breath, neck pain, back pain.   Treatment: toradol, zofran, Tylenol, Motrin, off work two weeks and counting.
Developed what was thought as rash on 7-14 early and lesions started at noon and became worse over next two days with crusted centers.
A COUPLE OF HOURS AFTER VACCINE, PALPITATIONS AND TACHYCARDIA. THIS LASTED FOR 5 DAYS, SO SHE WENT TO SEE A HEART DR. LATER THAT EVENING, TEMP OF 101.
A healthcare professional reported that a 19 month old female received Hib-Titer, DTAP and IPV vaccines on 3/30/01. It was determined that the child had received her 4th dose of Hib-Titer in January, 2001. On 4/2/01, the child developed a fever and swollen, red tonsils. She was seen in an ER and dx'd with tonsillitis. The child was treated with Zithromax (azithromycin). Follow-up information received from the physician on 5/18/01, indicated that the child was dx'd with pharyngitis. She received treatment and "did fine".
BODY ACHES; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced body ache, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever and body ache was not reported. This report was non-serious.
12/23 - dry, scratchy throat 12/24 - nasal discharge (mild) 12/25. - nasal discharge 12/26. - sinus congestion 12/27 - loss of taste / smell; diarrhea
Soreness at the injection site 24 hours after injection lasting 3 days. Axillary pain on side of vaccine, cough, body aches, itching and hives at vaccine site 7 days after injection.
Headache frequently, nausea, dizziness & vertigo.  Pain in the joints all the body, body aching, losing balance, high blood pressure.
Patient ended up going to hospital, so don't know if they did a VAERS or not. He was vomitting and had elevated liver enzymes and gall bladder issues
chronic migraine/persistent headache/migraines; This is a spontaneous report received from contactable reporter(s) (Other HCP) from a sales representative.  A 17 year-old female patient received bnt162b2 (BNT162B2), administration date 03Nov2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose Number: 01, Manufacturer: Unknown), for Covid-19 Immunization. The following information was reported: MIGRAINE (non-serious) with onset Nov2021, outcome "not recovered", described as "chronic migraine/persistent headache/migraines".  Additional information: The patient has had chronic migraine after 2nd dose of vaccine on 03Nov2021, seeing neurologist for persistent headache/migraines through 02Feb2022. Optional Information was not applicable. Event took place after use of product.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Information has been received from a Licensed Practitioner Nurse concerning a 21 year old female patient who on 21-JAN-2011 was vaccinated with a dose of GARDASIL (lot number not provided). The nurse reported that the patient last menses was on 21-DEC-2010 and at the time of the report had not yet had her menses. It was unspecified if the patient sought medical attention or if any treatment was given. On an unspecified date a pregnancy test was performed and was negative. At the time of the report the patient's outcome was unknown. Follow up information was received from the Licensed Practitioner Nurse concerning the 21 year old female patient with allergy to grass, wood and shavings and no illness at the time of vaccination. The nurse indicated that on 21-JAN-2011 at 9:29 am the patient was IM vaccinated with the first dose of GARDASIL (lot#667165/1167Z). It was reported that the patient stated she had not had a period since GARDASIL injection. It was also reported that on an unspecified date a urine pregnancy test was performed and resulted negative. Additional information ahs been requested.
Pfizer-BioNTech COVID-19 Vaccine EUA: one day after vaccine patient presents to emergency department (ED) after being shocked four times by ICD. Vital signs within normal ranges and lungs clear to auscultation. Admitted, device data reviewed, antiarrhythmic medications adjusted, and discharged home medically stable.
Vial was initially stored in refrigerator on 22-Aug-2022 and was administered on 04-Oct-2022; No adverse event; Dose administered after 30-day Use By Date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 22-Aug-2022 and was administered on 04-Oct-2022) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. 057A22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 04-Oct-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 04-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 22-Aug-2022 and was administered on 04-Oct-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 22-Aug-2022 and was administered on 04-Oct-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 22-Aug-2022 and was administered on 04-Oct-2022).    This case was reported for patient 2.  Concomitant medications were not reported. It was reported that the monovalent vial with the beyond use date as 21-Sep-2022 was initially stored in refrigerator on 22-Aug-2022. Individual vials or unbroken cartons are 2 doses. Vial size was 5.5 ml. The vial did not undergo any temperature excursion. Treatment medications were not reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-655852 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-655852:same reporter, Patient 1
Information has been received from an office manager referring to an unknown number of unspecified patients (age and gender unknown). The patients' concurrent conditions, concomitant medication and medical history were not provided. On unknown dates starting on or after 28-APR-2016, the patients were vaccinated with improperly stored doses of ROTATEQ (lot# L027719, expiry date 28-APR-2017; lot# L037574, expiry date 01-JUL-2017; lot# M002254, expiry date 15-NOV-2017, strength, dose and dose number were not provided) orally. The vaccine was exposed to a temperature of 28.6 F for a time frame of 885 hours. There was no previous temperature excursion. "Data logger" was involved. No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Plaque psoriasis.    Concurrent medical conditions included Plaque psoriasis.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate free. In 2021, the patient experienced DYSPNOEA (Shortness of breath). At the time of the report, DYSPNOEA (Shortness of breath) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Laboratory test: Nothing wrong.         No relevant concomitant medications were reported.   The reporter's causality for the event of shortness of breath with humira was not provided.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  No treatment information was provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   Most recent FOLLOW-UP information incorporated above includes: On 23-Dec-2021: Significant follow up received included therapy dates added, event date added, narrative updated.
I was 35 weeks pregnant at the time. I am due April 25. I?m not sure this was an adverse effect, but I had a high fever of 103.5 and some kind of restless leg syndrome. Both were short term - less than five hours.
This spontaneous report was received from a other health care worker via company representative refers to a 17 year old male patient. On an unknown date, the patient was vaccinated with third dose of GARDASIL (lot number, expiry date was unknown). On an unknown date, the patient experienced headache and nausea after taking the third shot. The outcome of headache and nausea was reported as not recovered/not resolved. Additional information is not expected.
Product temperature excursion issue; expired product administered; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) and EXPIRED PRODUCT ADMINISTERED (expired product administered) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939901) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Oct-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) and EXPIRED PRODUCT ADMINISTERED (expired product administered). On 12-Oct-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) and EXPIRED PRODUCT ADMINISTERED (expired product administered) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications was not reported. Treatment medications was not reported.
Slight fever,fatigue,lack of appetite,nausea ,high blood pressure ,headache,tiredness
patient was vaccinated and walked a few steps and said he felt like fainting . came back and sat down . we gave water and orange juice and felt fine after a few minutes
day following vax pt exp severe abd pain, some bleeding, vomiting cont does not drink/smoke;dx w/pancreatitis
On 9/30, DOH was notified by an health services company that a nurse had reused syringes for multiple persons earlier that day at am employee influenza vaccination clinic where the health services company had been contracted. The nurse contracted by the health services company brought three multiple-dose vials of vaccine that were intended for another event (and stored in her personal fridge without temp monitoring). The nurse reported using two syringes she found among her supplies to administer vaccine to 67 employees of the business. She reported wiping the syringes with alcohol and using a new needle for each of the 67 persons. Only 2 multiple dose vials of vaccine (10 doses/vial) were used for 67 adult participants. Participants were offered blood borne pathogen testing (hep N, hep C, HIV), hepatitis B vaccine, and flu vaccine.
pt recv vax 30AUG95 & 18OCT95 pt devel vesicular rash w/erythematous base on chest,abd,scalp & face;it was reported that 95% of these lesions were trunk;exp was reported to last 3ks w/no assoc fever or pruritus;
GOT COVID 01/2022, 2 WEEKS LATER GOT WIDESPREAD HIVES, HAD THEM FOR MONTHS UNTIL GOING TO AN ALLERGIST WHO TESTED ME FOR FOOD ALLERGIES
After 2 days of side-effects worsening I contacted healthcare provider and requested  in home visit, that visit ended wit a recommendation to go have emergency treatment. I was transported to the hospital  and was diagnosed with Pulmonary Embolisms in both lungs and a deteriorating right base of the right lung.
On 11/10/1949, the pt experienced a swollen leg, on 11/11/1999, the leg was still swollen, red to orange, at 2:30, the pt experienced a fever of 103 at 6:30 PM. Tylenol was given. On 11/12/99 the pt experienced a seizure at 7:45 AM. Taken to the ER at 8:00am discharged at 11:00am. Family hx of seizures.
Marked swelling erythema left arm extending to forearm, left olecranon fluid collection, T 100.5. Impression: left olecranon bursitis and cellulitis versus atypical Pneumovax reaction. Hypertension, glaucoma.
t105 @ 8PM 8APR91 given cotylenol; mom states on way home fr getting shot had high pitched short moan, also had stiff neck;
Patient has family member who are with COVID-19 infection; did not receive the second shot/pharmacist referred it´s being too long/vaccine after 42 days/unable to take the 2nd dose since it's longer than 42 days; 1 month of headache, like someone hit on top of her head; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE TO SARS-COV-2 (Patient has family member who are with COVID-19 infection), INTENTIONAL PRODUCT USE ISSUE (did not receive the second shot/pharmacist referred it´s being too long/vaccine after 42 days/unable to take the 2nd dose since it's longer than 42 days) and HEADACHE (1 month of headache, like someone hit on top of her head) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No medication history information was reported.  Concomitant products included CYCLOBENZAPRINE HYDROCHLORIDE (FLEXERIL [CYCLOBENZAPRINE HYDROCHLORIDE]) for Depression.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (1 month of headache, like someone hit on top of her head). On 05-Jun-2021, the patient experienced INTENTIONAL PRODUCT USE ISSUE (did not receive the second shot/pharmacist referred it´s being too long/vaccine after 42 days/unable to take the 2nd dose since it's longer than 42 days). On an unknown date, the patient experienced EXPOSURE TO SARS-COV-2 (Patient has family member who are with COVID-19 infection). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at a dose of 1 UNK. In May 2021, HEADACHE (1 month of headache, like someone hit on top of her head) had resolved. On 05-Jun-2021, INTENTIONAL PRODUCT USE ISSUE (did not receive the second shot/pharmacist referred it´s being too long/vaccine after 42 days/unable to take the 2nd dose since it's longer than 42 days) had resolved. At the time of the report, EXPOSURE TO SARS-COV-2 (Patient has family member who are with COVID-19 infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Follow up received and contains no new information.
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. No pertinent or historical conditions were reported. On unspecified dates starting on or after 21-OCT-2015, the patients were administered an unspecified number of improperly stored doses of oral, ROTATEQ (lot L000571, expiration date 26-JUL-2016, lot L008054, expiration date 30-NOV-2016, lot L008578, expiration date 14-DEC-2016, strength and dose unknown). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Received vaccines 4-25-08.  Started with a fever that afternoon, fussy.  4/28/08-Seen by doctor-pharyngitis.  Omnicef - Claritin started.
Pt states she awakened in the morning at approximately 7:00 am on 8/10/12 itching with a fine flat red rash over chest, abd, thighs and arms.  She noticed slight hives on abdomen as the day wore on.  She denied Dyspnea, dysphagia, or edema around face.  She called Immunizations and was told to call her medical provider immediately and come to the clinic.
Patient received her first dose Pfizer (LOT#: EW0182 EXP: 8/2021) at 1046 on 5/14/21. Patient alerted EMT . Patient stated that she felt hot around her neck area and moved to ears and shoulder region. Patient stated she also felt itchiness around her head area. EMT  took patients vital signs at 1110. BP: 128/84, pulse: 81, O2: 97%. Patient was given water and asked to stay an extra 30 minutes for further observation. EMT reassessed and re-took vital signs at 1120. BP: 124/82, pulse: 84, O2: 99%. Patient stated she was feeling better. EMT reassessed and retook final vitals for patient at 1130. BP: 118/78, pulse: 82, O2: 99%. Patient stated she felt no symptoms and felt fine to leave. Patient completed observation time. PHN educated patient on worsening signs and symptoms of vaccine and when to call EMS or go to emergency room or urgent care. Patient verbalized understanding of education. Patient left vaccination site at 1138 unassisted and with a steady gait.
Encephalopathy with hypoglycemia progressing to multiorgan failure with shock require ventilator support, vasopressor support, and progressive refractory lactic acidosis despite CRRT and broad spectrum antibiotic therapy.  Most recent cultures negative so far.
child had shot approx 11am-mom called at 4:30 pm stating child had c/o headache and vomited x 2 since injection. Advised to go to ER. 8/14/07 spoke with mom for follow up didn't go to ER-symptoms resolved by 9 pm that evening.
I received my injection and the site was painful to touch for 2 days but nothing else.  Starting on  Monday, Jan 11, I noticed soreness and the area around the injection site was  hard.  This continued until Friday Jan 15th but I also noticed swelling, the area is warm to the touch and skin redness.  I took 1000mg of Tylenol.  Today Saturday, Jan 16th I currently have soreness, skin redness, the are is swollen and is warm to the touch and it is hard.
Patient was given Bivalent booster instead of 2nd Monovalent dose of the primary series. No adverse reaction at that time.
around 10 pm started with chills and fatigue with a sore injection location. Around 11:30 pm he got light headed and passed out for 4 seconds. After awaking he doesn't remember the last 5 minutes. He laid down to go to sleep and was consistently hot and then cold. He does have a history of night terrors but they have remained dormant for about 2.5 years. Around 12 am he started having one of the worst night terrors I've seen. The following morning, April 2nd 2021, he was feeling incredibly sore and the injection spot was tender. He said "it feels like I got hit by a truck." Seems to be doing okay otherwise now.
Hoarseness, sore throat, pain below ears. Symptoms relieved by Advil and Zyrtec 10 mg.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 23-JAN-2015 the patient was inadvertently vaccinated with expired ZOSTAVAX (expiry date: 21-JAN-2015) (dose, lot number and route was unknown). No adverse effects were reported. Additional information has been requested.
it feels like a "booster shoot"; the whole arm is useless; feeling very very sore; the pain was all night; headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (it feels like a "booster shoot"), LIMB DISCOMFORT (the whole arm is useless), PAIN (feeling very very sore), PAIN (the pain was all night) and HEADACHE (headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Multiple sclerosis.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced FEELING ABNORMAL (it feels like a "booster shoot"), LIMB DISCOMFORT (the whole arm is useless), PAIN (feeling very very sore), PAIN (the pain was all night) and HEADACHE (headache). On 04-Mar-2021, HEADACHE (headache) had resolved. At the time of the report, FEELING ABNORMAL (it feels like a "booster shoot"), LIMB DISCOMFORT (the whole arm is useless), PAIN (feeling very very sore) and PAIN (the pain was all night) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's medical history included Multiple Sclerosis (MS). Concomitant medications reported were blood pressure medication and MS medications.  Treatment details included MOTRIN® (Ibuprofen) and Tylenol.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Non Significant follow up
Patient received flu shot, sat for 5 min afterwards but got dizzy and almost fainted when he stood up and tried to walk.
This spontaneous report as received from a registered nurse refers to unspecified patients of unknown age. It was reported that Nurse reported that one or two doses of GARDASIL (dose and lot# not reported) which was stored at temperatures outside of the current prescribing information might have been administered to patients on unspecified dates. No adverse events were reported. This is one of the several reports from the same reporter. Additional information has been requested.